Literature DB >> 20735171

Tracing the source of an outbreak of methicillin-resistant Staphylococcus aureus in a tertiary-care oncology hospital by epidemiology and molecular methods.

Patricia Cornejo-Juárez1, Patricia Volkow-Fernández, Jose Sifuentes-Osornio, Gabriela Echániz-Aviles, Adriana Díaz-Gonzalez, Consuelo Velázquez-Acosta, Miriam Bobadilla-Del-Valle, Patricia Gordillo-Molina, María E Velazquez-Meza.   

Abstract

This study describes the clinical and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) isolates that emerged after an index case in a tertiary-care oncology hospital in Mexico City and identifies whether these isolates were related with the index case. All MRSA strains isolated from January 2006 until December 2007 were included. The clinical and demographic characteristics of patients were analyzed; molecular typing by pulsed-field gel electrophoresis was used to characterize the isolates. We included 44 MRSA isolates from 55 patients. Thirty-eight patients (86.4%) were classified with nosocomial infection and the remainder with healthcare-related infection. A single pulsed-field gel electrophoresis pattern (C) was identified with minor variations (two subtypes). The isolates analyzed were staphylococcal chromosome cassette mec type II (related with the New York-Japan strain). This case underscores the need to intensify strategies that identify and limit the spread of multiresistant pathogens imported by infected patients referred from other healthcare centers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735171     DOI: 10.1089/mdr.2010.0048

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  1 in total

1.  Detection of capsular genotypes of methicillin-resistant Staphylococcus aureus and clonal distribution of the cap5 and cap8 genes in clinical isolates.

Authors:  Gabriela Echániz-Aviles; Maria Elena Velazquez-Meza; Brian Rodríguez-Arvizu; Maria Noemi Carnalla-Barajas; Araceli Soto Noguerón
Journal:  Arch Microbiol       Date:  2022-02-21       Impact factor: 2.552

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.